Navigation Links
Oncophage Cancer Vaccine Significantly Prolongs Recurrence-Free,Survival by 45 Percent in Patients With Intermediate-Risk Kidney,Cancer

ophage in ex-US markets.

Conference Call Information

Antigenics executives and Dr. Christopher Wood will host a conference call at 1:30 pm ET today. To access the live call, dial 888.271.9082 (domestic) or 706.679.7741 (international); the access code is 9197359. The call will also be webcast and will be accessible from the company's website at www.antigenics.com/webcast/. A replay will be available approximately two hours after the call through midnight ET on June 4, 2007. The replay number is 800.642.1687 (domestic) or 706.645.9291 (international), and the access code is 9197359. The replay will also be available on the company's website approximately two hours after the live call.

About Renal Cell Carcinoma

Renal cell carcinoma is the most common type of kidney cancer. The American Cancer Society estimates that there will be approximately 51,190 new cases of kidney cancer in the United States in 2007, and about 12,890 people will die from the disease. Renal cell carcinoma accounts for about 90 percent of all kidney tumors. By the time renal cell carcinoma is diagnosed in these patients, about one third of them will have developed metastatic disease.

The current standard of care for patients with nonmetastatic renal cell carcinoma consists of a nephrectomy (surgical removal of the kidney) followed by observation. There is no treatment approved by the US Food and Drug Administration for nonmetastatic renal cell carcinoma at the present time.

*Haas N. Update on targeted therapy adjuvant trials (ECOG/MRC). Paper presented at: Fifth International Symposium of the Kidney Cancer Association, 2006; Chicago.

About Antigenics

Antigenics (NASDAQ: AGEN) is a biotechnology company working to develop treatments for cancers and infectious diseases. The company's investigational product portfolio includes Oncophage(R) (vitespen), a patient-specific therapeutic cancer vaccine being evaluated in several indications; Aroplatin
'"/>




Page: 1 2 3 4 5 6

Related medicine technology :

1. Data from Investigator-Sponsored Trial of Oncophage Cancer Vaccine in Glioma Presented at American Association of Neurological Surgeons Annual Meeting
2. Breast Cancer and HER-2/neu: Diagnostic Tools for Targeted Therapy
3. Data Available From Erbitux Phase III Study in First-Line Treatment of Advanced Lung Cancer
4. Clinical Study Shows Regenecare Relieves Pain and Itching of Skin Rashes Caused by Widely Used Cancer Drugs
5. Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial
6. Protox Announces Positive Clinical Data from Prostate Cancer Study
7. Gene Therapy Eradicates Pancreatic Cancer in Preclinical Trial Targeting Systems Success in Mouse Model Reported in Cancer Cell
8. MediGene Announces Cancer-Fighting Virus Shows Promise in Early Clinical Trial
9. Response Genetics Announces Publication of a Phase III Clinical Trial Demonstrating That Low Levels of ERCC-1 Help to Predict Likelihood of Response to Cisplatin-Based Therapy in Lung Cancer
10. Study Shows Ixabepilone Demonstrated Clear Activity in Patients with Metastatic Breast Cancer Resistant to Anthracycline, Taxane, and Capecitabine
11. Peer Reviewed Journal Article Indicates Repros Proellex Exhibits Potential for New Approach to the Treatment and Prevention of Breast Cancer

Post Your Comments:
(Date:11/9/2009)... , INDIANAPOLIS, Nov. 9 AMD L...laser expert, Dr. James Jesse, has accepted the po...Jesse will be responsible for overseeing research ... lasers, standards and compliance for continuing e...eer reviews and trade publications, and lecturing ...
(Date:11/9/2009)... , LAKE MARY, Fla., Nov. 9 Ac... provider of outsourced implantable medical device...announced today that it is relocating its corporat...rompted by the firm,s continued rapid growth, incl...ary office space that will open in January 2010 an...
(Date:11/9/2009)... , ANN ARBOR, Mich., Nov. 9 ...e of Clinical Xpert(TM) CareFocus, a leading clini...o identify at-risk patients in real-time and respo...uce total cost of treatment. ,, This upgrade is...ditional cost. ,, CareFocus 2.0 contains seve...
Breaking Medicine Technology:AMD LASERS Names Dr. James Jesse as Medical Director 2Access MediQuip Moves Company Headquarters to Lake Mary, Florida 2Thomson Reuters Clinical Surveillance Solution Offers Powerful New Functionality to Improve Clinical Quality and Reduce Costs 2Thomson Reuters Clinical Surveillance Solution Offers Powerful New Functionality to Improve Clinical Quality and Reduce Costs 3Global warming increasing the dispersal of flora in Northern forests 8800 1Global warming increasing the dispersal of flora in Northern forests 8800 2Cinergy Health Expands Staff in Face of Dramatic Growth 48618 1Cinergy Health Expands Staff in Face of Dramatic Growth 48618 2Dr Philip A DeFina of International Brain Research Foundation Joins Montgomery Academy Board of Trustees 48614 1Dr Philip A DeFina of International Brain Research Foundation Joins Montgomery Academy Board of Trustees 48614 2
(Date:11/9/2009)...In the construction industry, respiratory disease,...of cancer, is a major public health concern. Stud... in Virginia Tech,s School of Construction, have s...ly effective in reducing the dust that causes thes...available technology remains very low. , To find...
(Date:11/9/2009)... lives of almost 4 million women, newborns, and ch...year if well-established, affordable health care i...ding to a joint report by the national science aca...ations are underutilizing existing scientific know...on scientists, health care providers, policymakers...
(Date:11/9/2009)... Dr. Mark Sweeney, a cosmetic dentist in Aust...ting participants to describe why they are The Mos...ner earns a cosmetic smile makeover worth up to $1...n Dental Spa’s website as well as YouTube an...ember 9, 2009 -- A prominent Austin cosmetic dent...
(Date:11/9/2009)... Partnership to Combine Self-service Kiosks an... Denver, CO (PRWEB) November 9...and AHA endorsed Vecna Technologies announced toda...l when interacting with providers by understanding...HSCorp’s HFMA peer reviewed product, ClearQu...
(Date:11/9/2009)... Supermodel Beverly Johnson teams with Ask4UFE...ring in silence understand their uterine fibroid t...and, MA (PRWEB) November 9, 2009 -- Fibroid tumors...ng, says supermodel Beverly Johnson, during a new...a campaign sponsored by BioSphere Medical and Ask4...
Breaking Medicine News(10 mins):Health News:Dust control research leads to a NIOSH grant to facilitate adoption of hazard controls 2Health News:Dust control research leads to a NIOSH grant to facilitate adoption of hazard controls 3Health News:Using science to save lives of mothers and children in Africa 2Health News:Using science to save lives of mothers and children in Africa 3Health News:Using science to save lives of mothers and children in Africa 4Health News:Austin Cosmetic Dentist Offers $15,000 Worth of Dental Work in Most Interesting Patient in the World Video Contest 2Health News:Austin Cosmetic Dentist Offers $15,000 Worth of Dental Work in Most Interesting Patient in the World Video Contest 3Health News:FHS Corp. Announces Partnership with Vecna Technologies 2Health News:New Series of Podcasts Highlight Supermodel's "Life-altering" Experience to Raise Awareness of Fibroid Treatment Options 2
...C., Oct. 25 PhoneTree(R) is unveiling,PhoneTree P...nt Association,(MGMA) 2007 Annual Conference, Octo...tions beginning at $99 per month, PhoneTree Patien...ective patient communication with prompt return on...
...ct. 25 The U.S. Department,of Health and Human Se...,today released Adapting Community Call Centers fo... Monitoring, a new report that recommends expandin...public shelters in the event of public health emer...
...e to Have Disproportionate Impact On Latinos, Othe...s, OAKLAND, Calif., Oct. 25 Sutter Health,s plan...o will have a particularly,adverse impact on the c...NOC presented the data at a San Francisco press,co...
... of Rochester Medical Center (URMC) announced toda...w York developer and philanthropist Richard T. Fie... the largest private donation for a specific dise...of muscular dystrophy. , The new Fields Center fo...
...tion of beta-amyloid clumps in mice, study says , ...e blood pressure drug valsartan shows the ability ...e, researchers report. , The potential value of va...etti, a professor of psychiatry and neurosciences ...
...5 /PRNewswire-FirstCall/ - SXC Health Solutions In...ordon S. Glenn, Chairman and,Chief Executive Offic...ber,8, 2007 at 8:30 a.m. ET to discuss the Company...terested parties can join the call by dialing 416-...
Other Medicine News:Health News:AHRQ Report Recommends Use of Existing Call Centers to Expand Communications in Public Health Emergencies 2Health News:CNA Presents New Data on Sutter's Medical Redlining 2Health News:CNA Presents New Data on Sutter's Medical Redlining 3Health News:New center to lead international muscular dystrophy research effort 2Health News:New center to lead international muscular dystrophy research effort 3Health News:New center to lead international muscular dystrophy research effort 4Health News:Blood Pressure Drug Might Work Against Alzheimer's 2Health News:SXC Health Solutions to Host Fiscal 2007 Third Quarter Financial Results Conference Call 2
...aneda Anterior Scoliosis System (KASS) is a two-ro...vides both flexibility of the implant for applicat...rect spinal deformities, and the ability to mainta...ling during graft incorporation. The fundamental a...
...fusion Monitor runs continuously and displays perf...omatic (autopilot) mode, the monitor periodically ...termined set of rules. The rules may be changed fo..., as well as tissue temperature, is displayed grap...
BLF21D Dual Channel
BLF21 Single Channel
Medicine Products: